Lung cancer is the second most common form of cancer and the leading cause of cancer-related fatalities in the United States (US). In the year 2020, an estimated 228,820 individuals received a diagnosis of lung cancer, while 135,720 lost their lives to this disease. The primary risk factor for developing lung cancer is smoking, accounting […]
Read More
For Thyroid Awareness Month 2025, we will be looking into the latest research and clinical trials focused on thyroid eye disease (TED) in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for TED, specifically targeting adults in the United States. Please note that the dates provided are approximate […]
Read More
Today, we will be looking into the latest research and clinical trials focused on hypertrophic cardiomyopathy in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for hypertrophic cardiomyopathy, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This […]
Read More
In this post, we will be taking a closer look at some of the most popular ophthalmology-related articles recently published across medical journals. Combining Paracentral Acute Middle Maculopathy and Peripapillary Fluid as Biomarkers in Anterior Ischemic Optic Neuropathy Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy 3-year Outcomes of Botulinum Toxin […]
Read More
January is Cervical Cancer Awareness Month, providing a valuable opportunity to increase awareness of cervical cancer and the importance of vaccination against human papillomavirus (HPV), the primary cause of cervical cancer. This year, the focus of Cervical Cancer Awareness Month is on emphasizing the significance of expanding access to HPV vaccines, regular screening, and cutting-edge […]
Read More
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2025 Guideline Central, All Rights Reserved.
Read More
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2025 Guideline Central, All Rights Reserved.
Read More
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
Read More
In the United States in 2022, stroke accounted for 1 in 6 deaths related to cardiovascular disease, according to the Centers for Disease Control and Prevention (CDC). The incidence rate of stroke experienced a slight decrease from 41.1 per 100,000 in 2021 to 39.5 per 100,000 in 2022. Ischemic strokes make up approximately 87% of […]
Read More
On October 25, 2022, the US Food and Drug Administration (FDA) granted approval for Johnson & Johnson’s Tecvayli® (teclistamab-cqyv) for the treatment of adult patients with relapsed or refractory multiple myeloma. This approval is specifically for patients who have previously received four or more prior lines of therapy, including a proteasome inhibitor, immunomodulatory drug, and […]
Read More